IDEX Corporation· IEX

Amundi Sells 268,259 Shares of IDEX Corporation $IEX

Amundi trimmed its holdings in IDEX Corporation (NYSE: IEX) by 18.0% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,219,400 shares of the industrial products company's stock after selling 268,259 shares during the quarter. Amundi owned about

IDEX Q2 Earnings Call Highlights

IDEX NYSE: IEX reported second-quarter 2026 results that exceeded its expectations, supported by growth in its Health & Science Technologies segment, stronger orders and operational execution. The company raised its full-year outlook for organic sales growth, adjusted EBITDA margin and adjusted earnings per share.

IDEX (NYSE:IEX) Sets New 52-Week High After Strong Earnings

IDEX Corporation (NYSE: IEX - Get Free Report)'s stock price reached a new 52-week high during trading on Wednesday following a better than expected earnings announcement. The stock traded as high as $232.55 and last traded at $239.8090, with a volume of 608 shares. The stock had previously closed at $224.65. The industrial products company reported

IDEX Beats Q2 Earnings Estimates on HST Momentum, Raises View

IEX tops second-quarter estimates, posts record orders above $1 billion and raises its 2026 outlook as demand improved across key end markets.

Compared to Estimates, Idex (IEX) Q2 Earnings: A Look at Key Metrics

The headline numbers for Idex (IEX) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Idex Corp. price target raised to $268 from $257 at Stifel

Idex Corp. price target raised to $257 from $250 at Stifel

Idex Corp. price target raised to $250 from $240 at Seaport Research